News | Published:

Class of once-weekly diabetes drugs poised for approval

Nature Medicine volume 17, page 1528 (2011) | Download Citation

  • A Correction to this article was published on 06 March 2012

This article has been updated

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Change history

  • 13 February 2012

     In the December 2011 issue, the article entitled 'Class of once-weekly diabetes drugs poised for approval' (Nat. Med. 17, 1528, 2011) incorrectly stated that the pharmaceutical company Eli Lilly is based in New York, when in fact its headquarters are in Indiana. The error has been corrected in the HTML and PDF versions of the article.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nm1211-1528b

Authors

  1. Search for Hannah Waters in:

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing